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Abstract 
Objective To assess the role of BAFF (B cell activating factor) receptor in B cell 
regulation of atherosclerosis. 
Methods and Results Male low-density lipoprotein receptor-deficient mice (Ldlr/) 
were lethally irradiated and reconstituted with either wild type or BAFF receptor (BAFF-
R)-deficient bone marrow. After 4 weeks of recovery, mice were put on a high fat diet for 
6 or 8 weeks. BAFF-R deficiency in bone marrow cells led to a marked reduction of 
conventional mature B2 cells but did not affect the B1a cell subtype. This was associated 
with a significant reduction of dendritic cell activation and T cell proliferation along with 
a reduction of IgG antibodies against malondialdehyde-modified LDL. In contrast, serum 
IgM type antibodies were preserved. Interestingly, BAFF-R deficiency was associated 
with a significant reduction in atherosclerotic lesion development and reduced numbers 
of plaque T cells. Selective BAFF-R deficiency on B cells led to a similar reduction in 
lesion size and T cell infiltration but in contrast did not affect dendritic cell activation. 
Conclusion BAFF-R deficiency in mice selectively alters mature B2 cell-dependent 
cellular and humoral immune responses, and limits the development of atherosclerosis. 
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Atherosclerosis is an inflammatory disease of the arterial wall driven by innate and 
adaptive immune responses to a variety of endogenous agents; the most studied ones 
being lipoproteins and heat shock proteins 1-4. Several inflammatory cell subsets have 
been shown to promote atherosclerosis, including monocytes/macrophages, neutrophils, 
mast cells and T lymphocytes. A notable exception was the proposed athero-protective 
role of the B lymphocyte subset 5, 6. However, these concepts have been refined during 
the last few years. For example, we and others have clearly shown that not all T 
lymphocytes are pro-atherogenic and have pinpointed T cell regulatory subsets with 
potent anti-atherogenic properties 7-9. More recently, we reconsidered the role of B 
lymphocytes in atherosclerosis. We clearly showed that contrary to expectations based on 
previous studies 5, 6, depletion of mature B cells in mice reduces lesion development, 
indicating the presence of a pro-atherogenic B cell subset 10. These results have been 
confirmed by another group of investigators 11 and have important consequences to our 
understanding of the immune response of atherosclerosis and the identification of suitable 
targets for disease modulation. A brief review of the previous and recent work on the role 
of B cells in atherosclerosis indicates that the pro-atherogenic effect is mainly driven by 
the common B2 subset, which responds to T cell-dependent antigens and is part of the 
adaptive immune response 10, 11. In contrast, the athero-protective effect is mostly 
attributed to the minor innate B1a subset, which responds to T cell-independent antigens 
and is responsible for the production of natural IgM antibodies 12, 13. This protective 
property may largely depend on the capacity of natural IgM to recognize oxidation-
specific epitopes on oxidized LDL and cellular debris 14.  However, a recent study has 
shown that B cell homing to atherosclerotic lesions might be important for the athero-
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protective effects of B cells, independently of IgM levels 15. Thus, more work is still 
needed to fully capture the multiple roles of B cell subtypes in atherosclerosis.  
Interestingly, the development, survival, proliferation and functions of the various B cell 
subsets are driven by distinct factors. One important factor is BAFF (B cell activating 
factor), a member of the tumor necrosis factor family 16. BAFF is produced both by 
hematopoietic and non-hematopoietic cells, and signals through 3 different receptors. 
BAFF is required for B cell maturation beyond the transitional T1 stage and supports the 
survival of low-affinity self-reactive B cells. As such, BAFF is involved in a variety of 
autoimmune-mediated diseases, and therapeutic strategies that interrupt its signaling 
pathways are currently approved or being tested in several clinical trials 16. The survival 
role of BAFF on the B2 cell subset is mediated through BAFF receptor (BAFF-R), 
mostly expressed on mature B cells 16. Mice deficient for BAFF-R show impaired B cell 
maturation beyond the transitional T1 stage and therefore marked depletion of mature B2 
cells. However, the B1 cell subset does not require BAFF-R signaling for its survival and 
is preserved in BAFF-R-deficient mice 16, 17. We therefore hypothesized that inhibition of 
BAFF-R signaling would reduce B2 pro-atherogenic activity while preserving B1 athero-
protective potential, thereby limiting lesion development. 
 
Methods 
We used male Ldlr/ and BAFF-R/ mice on C57Bl/6 background. Details of Methods 
can be found in the online Supplement. 
 
Results  
 Sage et al., BAFF-R and atherosclerosis 
 5 
In order to test this hypothesis, we subjected male Ldlr/ mice to lethal total body 
irradiation followed by reconstitution with either wild type or BAFF-R/ bone marrow 
(see Supplemental Methods). The mice were put on a high fat diet for 6 weeks to address 
the role of BAFF-R on immune responses and lesion development in the context of 
atherosclerosis. Body weights (WT: 32.6 ± 2.5 g, BAFF-R/: 33.2 ± 3.4 g) and plasma 
cholesterol levels (WT: 5.96 ± 0.73 g/l, BAFF-R/: 6.5 ± 0.74 g/l) did not differ between 
the 2 groups of mice. Mice reconstituted with BAFF-R/ bone marrow showed selected 
and marked depletion of B cells in bone marrow, blood, spleen and lymph nodes (Figure 
1A) compared with control mice. Monocyte numbers (in spleen, blood, bone marrow and 
peritoneum) were similar between the groups (data not shown). Numbers of T 
lymphocytes (CD4+ and CD8+ cells, determined in spleen and lymph nodes) were also 
similar between the groups, except for a significant reduction of CD4+ cells in spleen 
(Supplemental Fig. I). When we looked in more detail at the B cell subsets as exemplified 
by analysis of the peritoneal B cell population, we found a profound depletion of B2 cells 
(86% reduction) in face of a smaller reduction of B1b cells (48% reduction) and a 
preservation of innate and athero-protective B1a cells (Figure 1B and Supplemental Fig. 
II). We then addressed the impact of BAFF-R deficiency on both the humoral and 
cellular immune response. Total plasma Ig levels did not differ between the groups, 
except for IgG2c (Supplemental Fig. III). However, plasma levels of IgG1 and IgG2c 
antibodies to malondialdehyde (MDA)-modified LDL were significantly reduced in mice 
reconstituted with BAFF-R/ bone marrow compared with controls (Figure 1C). 
Interestingly, serum levels of total or anti-MDA-LDL IgM antibodies were not altered by 
BAFF-R deficiency (Figure 1C and data not shown), a finding consistent with the 
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preservation of B1a cells that are responsible for serum levels of natural IgM antibodies, 
shown to be athero-protective 12, 18. In a previous study from our group 10, we reported an 
important impact of mature B cell depletion on dendritic cell (DC) activation and T cell 
proliferation. In the present study, we also found a significant reduction of DC activation 
in mice reconstituted with BAFF-R/ bone marrow, as exemplified by the reduction of 
CD40 and MHC-II expression on CD11c+ DCs (Supplemental Fig. IV). BAFF-R 
deficiency was also associated with a marked reduction of T cell activation (Figure 1 D) 
and T effector cell proliferation (Figure 1E) in the absence of any change in the 
percentage or suppressive function of CD4+CD25+ regulatory T cells (data not shown). 
This finding suggests an important role for B2 cellsin the maintenance of effector T cell 
responses in the context of atherosclerosis. 
Finally, we addressed the effect of BAFF-R deficiency on the development of 
atherosclerotic lesions. As shown in Figure 2A, quantification of intimal area in the aortic 
root after Oil red O staining at 6 weeks of high fat diet revealed a significant reduction of 
lesion size in mice reconstituted with BAFF-R/ bone marrow compared with controls. 
Interestingly, BAFF-R deficiency was also associated with a reduction of lesion 
inflammation, as revealed by the significant decrease of total macrophage accumulation 
(MOMA2 staining) in the aortic root (Figure 2B) and a trend towards decreased ratio of 
MOMA2 staining to total lesion area (0.59  0.29 vs 0.84  0.35, P=0.11). The reduction 
of lesion size in mice reconstituted with BAFF-R/ bone marrow was also significant 
after 8 weeks on high fat diet (Figure 2A) despite similar serum cholesterol levels 
between the 2 groups of mice (8.65  1.36 vs 8.50  1.03 g/L, P=0.82). Selective BAFF-
R deficiency on B cells (see Supplemental Methods) did not alter T cell count 
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(Supplemental Fig. I) but led to selective depletion of B2 cells, associated with a 
reduction of T cell activation despite no change in DC activation (Supplemental Fig. V). 
Spleen T cells from these mice (20% BAFF-R-/- T cells) showed the same reduction in 
proliferation in vitro compared to controls as mice with 100% BAFF-R-/- T cells (data not 
shown), indicating the affect is due to the lack of B cells rather than BAFF-R on T cells. 
Indeed, we did not detect expression of BAFF-R on freshly isolated spleen T cells by 
flow cytometry (data not shown). Interestingly, selective BAFF-R deficiency on B cells 
also led to a significant reduction of lesion development (Figure 2A) despite no change in 
serum cholesterol levels (9.84  1.45 vs 9.84  1.82 g/L, P=1.00). Additionally, BAFF-R 
deficiency, whether in all cells or selectively in B cells, led to decreased numbers of T 
cells present in atherosclerotic plaque (Figure 2C). 
 
Discussion 
We have presented three different experiments showing that BAFF-R deficiency in bone 
marrow-derived cells reduces atherosclerosis. BAFF-R deficiency is associated with a 
reduction of T cell activation, reduced T cell numbers in plaques and attenuation of 
adaptive humoral responses against MDA-LDL. This contrasts with the preservation of 
the B1a cell subtype and the production of natural IgM antibodies. The result is a 
significant attenuation of macrophage accumulation within the vessel wall and thus a 
reduction of lesion development in Ldlr/ mice. During the review process, Kyaw et al. 
reported reduction of lesion development in Apoe//BAFF-R/ compared with Apoe/ 
mice 19, which is in agreement with the present results. Our studies on the mixed 
MT/BAFF-R chimeras also show that BAFF-R expression on B cells is sufficient to 
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drive T cell activation and atherogenesis, which is a unique and novel aspect. In addition, 
and in contrast to BAFF-R deficiency in total bone marrow-derived cells, DC activation 
is not altered in mice with selective BAFF-R deficiency in B cells. These results indicate 
that BAFF-R signaling in B cells directly drives T cell activation/proliferation and 
atherosclerosis independently of DC activation. Finally, our results clearly suggest that 
blockade of BAFF-R signaling may constitute an interesting therapeutic strategy to limit 
the development of atherosclerosis, particularly in patients with associated BAFF-
dependent immune-mediated diseases. 
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FIGURE LEGENDS 
Figure 1. BAFF-R deficiency in bone marrow cells markedly depletes B2 cells, alters the 
production of anti-MDA-LDL antibodies and impairs T cell activation and proliferation. 
A) Percentages of B lymphocytes (see Supplemental Methods) in bone marrow (BM), 
blood (Bl), spleen (Sp) and lymph nodes (Ln) of Ldlr/ mice reconstituted with either a 
wild type (WT, n=11) or BAFF-R/ (n=10) bone marrow and fed a high fat diet for 6 
weeks. B) Percentages of peritoneal B cell subsets (see Supplemental Methods) in the 
same groups of mice. C) Plasma antibody (IgG1, IgG2c and IgM) levels against MDA-
modified LDL in the same groups of mice. D) Quantitative analysis of CD69+ and 
CD44high expression using flow cytometry on spleen-derived CD4+ cells in the 2 groups 
of mice after 8 weeks of high fat diet. E) T effector cell proliferation using tritiated 
thymidine after stimulation of purified spleen-derived CD4+CD25 with anti-CD3 
antibody (see Methods). Mean values  S.D. are represented ( s.e.m. for T cell 
proliferation). *P<0.05. 
 
Figure 2. BAFF-R deficiency in bone marrow cells reduces the development of 
atherosclerosis. A-C) Ldlr/ mice were lethally irradiated and reconstituted with either a 
wild type or BAFF-R/ bone marrow, or a mixture of 80% bone marrow from MT mice 
and 20% bone marrow from either WT (MT/WT) or BAFF-R/ mice (MT/BR-/-). 
After 4 weeks of recovery, they were fed a high fat diet for 6 or 8 weeks. A) Quantitative 
analysis of intimal lesion area at the aortic root on Oil red O-stained sections. B) 
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Quantitative analysis of macrophage area at the aortic root on MOMA2-stained sections. 
C) Quantitative analysis of T cell numbers at the aortic root on CD3-stained sections. 
*P<0.05.  
 
 
 
 
